Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.
Under the Trump administration, a significant campaign is underway to reduce the civilian federal workforce, impacting over ...
JILA researchers are pioneering a nuclear clock using thorium-229, which offers unprecedented stability compared to atomic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback